GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MRT Inc (TSE:6034) » Definitions » EV-to-EBITDA

MRT (TSE:6034) EV-to-EBITDA : 2.14 (As of May. 27, 2024)


View and export this data going back to 2014. Start your Free Trial

What is MRT EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, MRT's enterprise value is 円1,179 Mil. MRT's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was 円550 Mil. Therefore, MRT's EV-to-EBITDA for today is 2.14.

The historical rank and industry rank for MRT's EV-to-EBITDA or its related term are showing as below:

TSE:6034' s EV-to-EBITDA Range Over the Past 10 Years
Min: 0.96   Med: 21.25   Max: 442.73
Current: 2.14

During the past 9 years, the highest EV-to-EBITDA of MRT was 442.73. The lowest was 0.96. And the median was 21.25.

TSE:6034's EV-to-EBITDA is ranked better than
96.56% of 465 companies
in the Healthcare Providers & Services industry
Industry Median: 12.65 vs TSE:6034: 2.14

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), MRT's stock price is 円699.00. MRT's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was 円31.180. Therefore, MRT's PE Ratio for today is 22.42.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


MRT EV-to-EBITDA Historical Data

The historical data trend for MRT's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MRT EV-to-EBITDA Chart

MRT Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Dec20 Dec21 Dec22
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only 115.66 24.42 18.30 5.48 1.64

MRT Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.48 1.86 2.03 1.85 3.21

Competitive Comparison of MRT's EV-to-EBITDA

For the Medical Care Facilities subindustry, MRT's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MRT's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MRT's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where MRT's EV-to-EBITDA falls into.



MRT EV-to-EBITDA Calculation

MRT's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1179.095/550.091
=2.14

MRT's current Enterprise Value is 円1,179 Mil.
MRT's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円550 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MRT  (TSE:6034) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

MRT's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=699.00/31.180
=22.42

MRT's share price for today is 円699.00.
MRT's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円31.180.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


MRT EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of MRT's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


MRT (TSE:6034) Business Description

Traded in Other Exchanges
N/A
Address
1-18-2 Kanan, 3rd Floor, Frame Kananzaka, Shibuya-ku, Tokyo, JPN, 150-0041
MRT Inc engages in the business of medical personnel placement services through Internet. It provides part-time and full-time physician referral services through physician referral site MedRT.com; as well as part-time job referral; job change introduction services to nurses, pharmacists, clinical laboratory technicians, clinical engineers and radiologists. Further, the company engages in the research and development of analytical and analytical methods for various biological samples, such as microorganisms, blood, proteins, and genes; and research and development, manufacture, and sale of medical and medical examination equipment, and analytical instruments.

MRT (TSE:6034) Headlines

No Headlines